Hovione and GEA announce a strategic collaboration to advance Continuous Tableting
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.
Pharmaceutical Technology, 10 October 2022
The new ConsiGma® CDC Flex delivers unprecedented flexibility, simplicity, and cost-efficiency in continuous direct compression.
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents